Archive · 21 May 2025
Bharat Biotech's Hillchol Oral Cholera Vaccine Completes Trials
Imagine a vaccine to fight cholera, a sickness that gives you bad tummy troubles.
A company called Bharat Biotech made a new one named Hillchol, and they finished the important tests.
The tests showed it worked well for all ages and is safe.
This new vaccine can be made easily, which makes it cheaper and helps more people.
They can make lots of doses and help with a global shortage of vaccines, especially in places where resources are limited.
Bharat Biotech's oral cholera vaccine, Hillchol, completed Phase III clinical trials.
The vaccine showed effectiveness against both Ogawa and Inaba serotypes.
Hillchol resulted in an over four-fold increase in vibriocidal antibodies.
Trials involved 1,800 participants at 10 clinical sites in India.
The vaccine features a simplified strain for better production and affordability.
- Who
- Bharat Biotech developed the Hillchol oral cholera vaccine.
- What
- Bharat Biotech completed Phase III trials for its oral cholera vaccine, Hillchol.
- When
- The Phase III clinical trials have recently completed.
- Where
- The clinical trials were conducted across 10 sites in India.
- Why
- To assess the safety, effectiveness, and consistency of the Hillchol vaccine.
- Company
- Bharat Biotech
- Vaccine Name
- Hillchol
- Vaccine Type
- Oral Cholera Vaccine
- Trial Phase
- Phase III
- Participants
- 1,800
- Trial Location
- India
- Potential Doses Annually
- 200 million
